Health care companies in the United States by short interest
Shares sold short and not yet covered, as reported to FINRA for the latest settlement date, as a percent of shares outstanding (market value divided by share price), not of the smaller float.
Hims & Hers Health leads the 140 health care companies in the United States ranked by short interest, at 22.0%, ahead of Scholar Rock Holding (19.2%) and TG Therapeutics (19.0%). Figures as of the 30 Oct 2026 settlement date, from FINRA's short interest report, with shares outstanding from Yahoo Finance quotes.
Key facts
- Companies ranked
- 140
- First
- Hims & Hers Health22.0%
- Median
- 5.35%
- Combined market value
- ZAR 128.39T
- Countries
- 1
Market values as of .
United States▾
Health Care▾
All categories▾
| # | Company | Short interest % ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | Hims & Hers HealthHIMS · Health Care | 22.0% | ZAR 60.2B | ZAR 256.75 | 8.86% down | 54% down | ||
| 2 | Scholar Rock HoldingSRRK · Health Care | 19.2% | ZAR 103.3B | ZAR 846.40 | 4.45% down | 25% up | ||
| 3 | TG TherapeuticsTGTX · Health Care | 19.0% | ZAR 168.4B | ZAR 1,113.88 | 2.37% down | 103% up | ||
| 4 | GRAILGRAL · Health Care | 17.8% | ZAR 78.5B | ZAR 1,745.39 | 5.33% down | 12% up | ||
| 5 | Rhythm PharmaceuticalsRYTM · Health Care | 16.8% | ZAR 137B | ZAR 1,975.94 | 3.80% down | 15% up | ||
| 6 | Dianthus TherapeuticsDNTH · Health Care | 16.5% | ZAR 83.7B | ZAR 1,486.88 | 0.33% down | 105% up | ||
| 7 | Protagonist TherapeuticsPTGX · Health Care | 15.7% | ZAR 139.3B | ZAR 2,134.92 | 2.11% down | 45% up | ||
| 8 | Praxis Precision MedicinesPRAX · Health Care | 15.1% | ZAR 147.7B | ZAR 5,283.30 | 3.37% down | 83% up | ||
| 9 | Twist BioscienceTWST · Health Care | 14.4% | ZAR 123.9B | ZAR 1,816.96 | 7.44% down | 291% up | ||
| 10 | CytokineticsCYTK · Health Care | 12.9% | ZAR 124.4B | ZAR 893.01 | 1.32% down | 21% down | ||
| 11 | Ionis PharmaceuticalsIONS · Health Care | 12.7% | ZAR 77.8B | ZAR 467.43 | 2.35% down | 64% down | ||
| 12 | Kodiak SciencesKOD · Health Care | 12.4% | ZAR 111.7B | ZAR 1,708.81 | 0.75% down | 371% up | ||
| 13 | Ligand PharmaceuticalsLGND · Health Care | 12.3% | ZAR 100.9B | ZAR 5,044.49 | 0.03% down | 44% up | ||
| 14 | Spyre TherapeuticsSYRE · Health Care | 12.2% | ZAR 156.1B | ZAR 1,643.74 | 4.26% down | 302% up | ||
| 15 | Halozyme TherapeuticsHALO · Health Care | 12.0% | ZAR 183.2B | ZAR 1,606.46 | 1.82% down | 32% up | ||
| 16 | ImmunityBioIBRX · Health Care | 11.9% | ZAR 112.6B | ZAR 105.87 | 8.37% down | 216% up | ||
| 17 | Edgewise TherapeuticsEWTX · Health Care | 11.6% | ZAR 76.8B | ZAR 701.76 | 3.07% down | 82% up | ||
| 18 | RadNetRDNT · Health Care | 11.3% | ZAR 96.6B | ZAR 1,225.91 | 0.29% up | 16% down | ||
| 19 | RepligenRGEN · Health Care | 11.0% | ZAR 184.1B | ZAR 2,880.73 | 3.81% down | 5% up | ||
| 20 | BridgeBio PharmaBBIO · Health Care | 10.7% | ZAR 260.5B | ZAR 1,337.05 | 2.75% down | 15% up | ||
| 21 | ErascaERAS · Health Care | 10.6% | ZAR 84B | ZAR 239.34 | 4.29% down | 387% up | ||
| 22 | ExelixisEXEL · Health Care | 10.5% | ZAR 277.3B | ZAR 1,136.57 | 1.82% down | 55% up | ||
| 23 | CG OncologyCGON · Health Care | 10.3% | ZAR 124.8B | ZAR 1,397.54 | 2.97% down | 93% up | ||
| 24 | Krystal BiotechKRYS · Health Care | 10.3% | ZAR 161B | ZAR 5,432.08 | 2.19% down | 49% up | ||
| 25 | TeleflexTFX · Health Care | 10.3% | ZAR 112.7B | ZAR 2,841.51 | 1.11% down | 48% up | ||
| 26 | Cogent BiosciencesCOGT · Health Care | 10.0% | ZAR 81.7B | ZAR 469.80 | 3.70% down | 25% down | ||
| 27 | Mirum PharmaceuticalsMIRM · Health Care | 9.99% | ZAR 110.4B | ZAR 1,690.52 | 0.65% up | 35% up | ||
| 28 | Travere TherapeuticsTVTX · Health Care | 9.96% | ZAR 79.3B | ZAR 826.53 | 2.69% down | 39% up | ||
| 29 | Kymera TherapeuticsKYMR · Health Care | 9.84% | ZAR 173.1B | ZAR 2,027.82 | 3.42% down | 81% up | ||
| 30 | VaxcytePCVX · Health Care | 9.70% | ZAR 154.2B | ZAR 974.08 | 5.09% down | 22% up | ||
| 31 | Oruka TherapeuticsORKA · Health Care | 9.53% | ZAR 114.3B | ZAR 1,684.90 | 1.80% down | 233% up | ||
| 32 | 10x GenomicsTXG · Health Care | 9.48% | ZAR 119.8B | ZAR 910.94 | 9.72% down | 213% up | ||
| 33 | PTC TherapeuticsPTCT · Health Care | 9.31% | ZAR 82.9B | ZAR 992.19 | 3.27% down | 26% down | ||
| 34 | Madrigal PharmaceuticalsMDGL · Health Care | 9.20% | ZAR 154.9B | ZAR 6,666.78 | 4.45% down | 28% down | ||
| 35 | ImmunovantIMVT · Health Care | 8.96% | ZAR 115.6B | ZAR 558.70 | 2.31% down | 44% up | ||
| 36 | Henry ScheinHSIC · Health Care | 8.47% | ZAR 162.4B | ZAR 1,468.77 | 1.51% down | 16% up | ||
| 37 | Corcept TherapeuticsCORT · Health Care | 8.34% | ZAR 122.4B | ZAR 1,118.81 | 2.09% down | 16% down | ||
| 38 | ModernaMRNA · Health Care | 8.20% | ZAR 1.39T | ZAR 3,429.23 | 2.17% down | 740% up | ||
| 39 | Arrowhead PharmaceuticalsARWR · Health Care | 8.19% | ZAR 102.8B | ZAR 727.52 | 5.22% down | 8% up | ||
| 40 | DaVitaDVA · Health Care | 8.17% | ZAR 178.1B | ZAR 2,831.84 | 3.00% up | 30% up | ||
| 41 | VeradermicsMANE · Health Care | 8.03% | ZAR 88.7B | ZAR 2,101.85 | 3.92% down | 230% up | ||
| 42 | HaemoneticsHAE · Health Care | 7.90% | ZAR 96.2B | ZAR 2,113.11 | 0.17% down | 53% up | ||
| 43 | InsuletPODD · Health Care | 7.68% | ZAR 162.5B | ZAR 2,341.90 | 2.96% down | 59% down | ||
| 44 | GlaukosGKOS · Health Care | 7.57% | ZAR 247B | ZAR 4,173.29 | 0.33% down | 139% up | ||
| 45 | ResMedRMD · Health Care | 7.44% | ZAR 582.8B | ZAR 4,143.74 | 0.53% down | 6% down | ||
| 46 | BrukerBRKR · Health Care | 7.37% | ZAR 151.6B | ZAR 992.89 | 9.08% down | 31% up | ||
| 47 | BioMarin PharmaceuticalBMRN · Health Care | 7.29% | ZAR 205.8B | ZAR 1,062.36 | 1.64% down | 12% up | ||
| 48 | Globus MedicalGMED · Health Care | 7.14% | ZAR 155.8B | ZAR 1,176.31 | 2.49% down | 20% down | ||
| 49 | Adaptive BiotechnologiesADPT · Health Care | 7.09% | ZAR 79.5B | ZAR 491.17 | 0.43% down | 51% up | ||
| 50 | Definium TherapeuticsDFTX · Health Care | 7.02% | ZAR 68.2B | ZAR 498.38 | 3.87% down | 176% up | ||
| 51 | Guardant HealthGH · Health Care | 6.97% | ZAR 346.9B | ZAR 2,564.54 | 0.16% up | 38% up | ||
| 52 | Merit Medical SystemsMMSI · Health Care | 6.67% | ZAR 88.9B | ZAR 1,483.19 | 0.08% down | 3% down | ||
| 53 | HealthEquityHQY · Health Care | 6.62% | ZAR 137.8B | ZAR 1,666.25 | 2.70% down | 4% down | ||
| 54 | Elanco Animal HealthELAN · Health Care | 6.59% | ZAR 226.3B | ZAR 452.66 | 2.09% down | 18% up | ||
| 55 | HeartflowHTFL · Health Care | 6.47% | ZAR 72.2B | ZAR 821.08 | 4.62% up | 45% up | ||
| 56 | InsmedINSM · Health Care | 6.42% | ZAR 545.2B | ZAR 2,485.40 | 2.17% down | 27% down | ||
| 57 | Charles River Laboratories InternationalCRL · Health Care | 6.23% | ZAR 264.9B | ZAR 5,527.57 | 4.15% down | 96% up | ||
| 58 | BillionToOneBLLN · Health Care | 6.22% | ZAR 75.5B | ZAR 1,581.32 | 0.31% down | 18% down | ||
| 59 | Axsome TherapeuticsAXSM · Health Care | 6.20% | ZAR 119.7B | ZAR 2,274.90 | 4.66% down | 9% down | ||
| 60 | ChemedCHE · Health Care | 6.14% | ZAR 125B | ZAR 9,647.39 | 0.50% down | 25% up | ||
| 61 | Legend BiotechLEGN · Health Care | 6.13% | ZAR 52B | ZAR 268.18 | 5.28% down | 43% down | ||
| 62 | PenumbraPEN · Health Care | 6.10% | ZAR 221.2B | ZAR 5,611.98 | 0.28% down | 11% up | ||
| 63 | Revolution MedicinesRVMD · Health Care | 6.05% | ZAR 613.2B | ZAR 2,834.83 | 1.11% up | 125% up | ||
| 64 | RevvityRVTY · Health Care | 5.85% | ZAR 285.1B | ZAR 2,553.81 | 4.20% down | 54% up | ||
| 65 | BrightSpring Health ServicesBTSG · Health Care | 5.83% | ZAR 220.1B | ZAR 1,105.97 | 1.77% down | 85% up | ||
| 66 | Align TechnologyALGN · Health Care | 5.83% | ZAR 192.3B | ZAR 2,728.79 | 2.82% down | 12% up | ||
| 67 | Neurocrine BiosciencesNBIX · Health Care | 5.83% | ZAR 268B | ZAR 2,647.89 | 3.84% down | 10% up | ||
| 68 | Molina HealthcareMOH · Health Care | 5.59% | ZAR 182.1B | ZAR 3,488.85 | 2.43% down | 44% up | ||
| 69 | Lantheus HoldingsLNTH · Health Care | 5.57% | ZAR 117.4B | ZAR 1,795.51 | 0.00% | 83% up | ||
| 70 | Oscar HealthOSCR · Health Care | 5.39% | ZAR 135.1B | ZAR 434.90 | 5.50% down | 94% up | ||
| 71 | Cooper CompaniesCOO · Health Care | 5.32% | ZAR 196.9B | ZAR 1,035.45 | 2.40% down | 20% down | ||
| 72 | IlluminaILMN · Health Care | 5.31% | ZAR 512.7B | ZAR 3,390.89 | 3.90% down | 62% up | ||
| 73 | Summit TherapeuticsSMMT · Health Care | 5.28% | ZAR 139.9B | ZAR 174.98 | 5.87% down | 35% down | ||
| 74 | IncyteINCY · Health Care | 5.22% | ZAR 410.9B | ZAR 2,015.77 | 1.07% down | 14% up | ||
| 75 | Medpace HoldingsMEDP · Health Care | 4.95% | ZAR 300.3B | ZAR 10,736.83 | 3.70% down | 7% up | ||
| 76 | Bio-TechneTECH · Health Care | 4.90% | ZAR 200.8B | ZAR 1,277.96 | 0.04% down | 18% up | ||
| 77 | Baxter InternationalBAX · Health Care | 4.58% | ZAR 231B | ZAR 446.50 | 0.00% | 39% up | ||
| 78 | Universal Health ServicesUHS · Health Care | 4.42% | ZAR 181.9B | ZAR 3,155.42 | 2.54% up | 25% down | ||
| 79 | United TherapeuticsUTHR · Health Care | 4.31% | ZAR 415.5B | ZAR 9,755.37 | 0.78% down | 18% up | ||
| 80 | Bio-Rad LaboratoriesBIO · Health Care | 4.30% | ZAR 169.7B | ZAR 6,311.54 | 2.34% down | 16% up | ||
| 81 | DexComDXCM · Health Care | 4.27% | ZAR 520.2B | ZAR 1,394.91 | 1.08% down | 33% up | ||
| 82 | NateraNTRA · Health Care | 4.19% | ZAR 697.2B | ZAR 4,807.96 | 5.70% down | 26% up | ||
| 83 | Zimmer Biomet HoldingsZBH · Health Care | 4.15% | ZAR 336.5B | ZAR 1,777.92 | 0.36% down | 10% up | ||
| 84 | ZoetisZTS · Health Care | 4.12% | ZAR 565.3B | ZAR 1,391.21 | 2.08% down | 34% down | ||
| 85 | Option Care HealthOPCH · Health Care | 4.10% | ZAR 83.2B | ZAR 555.54 | 0.06% down | 7% up | ||
| 86 | Alnylam PharmaceuticalsALNY · Health Care | 4.08% | ZAR 338.8B | ZAR 2,529.19 | 2.71% down | 66% down | ||
| 87 | GE HealthCare TechnologiesGEHC · Health Care | 4.04% | ZAR 641.2B | ZAR 1,418.12 | 1.53% down | 7% up | ||
| 88 | Caris Life SciencesCAI · Health Care | 4.01% | ZAR 88.7B | ZAR 309.16 | 5.18% down | 23% down | ||
| 89 | AvantorAVTR · Health Care | 3.97% | ZAR 176.8B | ZAR 260.97 | 1.85% down | 31% up | ||
| 90 | BiogenBIIB · Health Care | 3.69% | ZAR 648.8B | ZAR 4,389.24 | 1.00% up | 41% up | ||
| 91 | Encompass HealthEHC · Health Care | 3.68% | ZAR 230.6B | ZAR 2,350.34 | 1.04% up | 16% up | ||
| 92 | LifeStance Health GroupLFST · Health Care | 3.59% | ZAR 92.4B | ZAR 243.04 | 3.60% up | 107% up | ||
| 93 | MiniMed GroupMMED · Health Care | 3.49% | ZAR 79.2B | ZAR 281.55 | 1.54% down | 12% down | ||
| 94 | Belite BioBLTE · Health Care | 3.40% | ZAR 91B | ZAR 2,240.08 | 15.65% down | 25% up | ||
| 95 | Quest DiagnosticsDGX · Health Care | 3.39% | ZAR 499.7B | ZAR 4,542.06 | 0.31% down | 35% up | ||
| 96 | Cardinal HealthCAH · Health Care | 3.28% | ZAR 1.11T | ZAR 4,797.58 | 0.17% up | 30% up | ||
| 97 | Amneal PharmaceuticalsAMRX · Health Care | 3.27% | ZAR 129.4B | ZAR 371.41 | 1.26% down | 79% up | ||
| 98 | Labcorp HoldingsLH · Health Care | 3.13% | ZAR 524.2B | ZAR 6,456.27 | 0.47% down | 39% up | ||
| 99 | Mettler-Toledo InternationalMTD · Health Care | 3.10% | ZAR 583.1B | ZAR 29,313.42 | 2.27% down | 17% up | ||
| 100 | ViatrisVTRS · Health Care | 3.07% | ZAR 395.8B | ZAR 345.21 | 1.26% down | 90% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; short interest from FINRA, the owner and source of the data, as of the 30 Oct 2026 settlement date.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Source: FINRA. Short interest is the shares sold short and not yet covered as brokers reported them to FINRA for the 30 Oct 2026 settlement date; FINRA publishes it about seven business days later, so it is not today's figure. It is divided by shares outstanding worked out as the market value over the share price, both from the same quote — not by the float, so the percent reads lower than a percent of float would. For a company with more than one class of shares the market value covers every class, which lowers it further. Sums are converted from US dollars at today's exchange rate (1 USD = 17.5858 ZAR).
Questions and answers
Which health care companies in the United States rank first by short interest?
Hims & Hers Health (22.0%), Scholar Rock Holding (19.2%) and TG Therapeutics (19.0%) are the top three of the 140 health care companies in the United States ranked by short interest as of the 30 Oct 2026 settlement date.
How many health care companies in the United States are in this ranking?
140 are ranked by short interest.
What are these health care companies in the United States worth together?
The 140 health care companies in the United States ranked by short interest have a combined market value of ZAR 128.39T as of the 30 Oct 2026 settlement date.
What does ranking by short interest measure?
Shares sold short and not yet covered, as reported to FINRA for the latest settlement date, as a percent of shares outstanding (market value divided by share price), not of the smaller float.
Learn how this ranking works
All markets guides →- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
- How companies are sorted into sectors and industries
Companies are sorted into sectors and industries by classification systems. The index providers MSCI and S&P Dow Jones Indices use GICS: 11 sectors split into 25 industry groups, 74 industries and 163 sub-industries. SEC filings carry a four-digit SIC code. The two can place one company differently, because each looks at the business from its own angle.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
Cite this page
Funkfolio, “Health care companies in the United States by short interest”, data as of 21 November 2026. https://funkfolio.com/companies/sector/health-care?country=united-states&by=short-interest
Underlying data: FINRA short interest (the 30 Oct 2026 settlement date); Yahoo Finance.